The Doctor’s Advocate | Fourth Quarter 2020
Foundation News

Dr. David Feldman Joins Foundation Board of Directors

David L. Feldman, MD, MBA, CPE, FAAPL, FACS, has joined the Board of Directors of The Doctors Company Foundation. Dr. Feldman is chief medical officer (CMO) for TDC Group. He is also senior vice president and CMO at Healthcare Risk Advisors (HRA), formerly Hospitals Insurance Company and FOJP Service Corporation.

Prior to HRA, Dr. Feldman was vice president for patient safety, vice president of perioperative services, and vice chairman of the department of surgery at Maimonides Medical Center in Brooklyn, New York.

Dr. Feldman also serves on the steering committee of the American College of Surgeons (ACS) for retraining and retooling of practicing surgeons and has served on the ACS committee on perioperative care and as vice chairman of the ACS collaborative task force for the development of high-performance teams in surgery. Additionally, he served as the ACS liaison to the Association of Perioperative Registered Nurses recommended practices committee.

The Board of Directors leads the Foundation in accomplishing its mission to support patient safety education for healthcare professionals in training and in practice and patient safety research with clinically useful applications.

The Doctor’s Advocate is published by The Doctors Company to advise and inform its members about loss prevention and insurance issues.

The guidelines suggested in this newsletter are not rules, do not constitute legal advice, and do not ensure a successful outcome. They attempt to define principles of practice for providing appropriate care. The principles are not inclusive of all proper methods of care nor exclusive of other methods reasonably directed at obtaining the same results.

The ultimate decision regarding the appropriateness of any treatment must be made by each healthcare provider considering the circumstances of the individual situation and in accordance with the laws of the jurisdiction in which the care is rendered.

The Doctor’s Advocate is published quarterly by Corporate Communications, The Doctors Company. Letters and articles, to be edited and published at the editor’s discretion, are welcome. The views expressed are those of the letter writer and do not necessarily reflect the opinion or official policy of The Doctors Company. Please sign your letters, and address them to the editor.

Fourth Quarter 2020

From the Chairman
COVID-19: A Call for Innovation and Leadership in Healthcare

New Telehealth White Paper

Perspectives from the CMO
Could COVID-19 Bring More Patient-Centered Care to Your Practice?

An Ounce of Prevention
The Role of Pretest Probability in the Evaluation of Suspected Venous Thromboembolism